Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvano Paternoster

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|November 11, 2019
The intricate relationship between diabetes, obesity and pancreatic cancerSilvano Paternoster, Marco Falasca
Translational Andrology and Urology|August 9, 2019
Targeting the adipose tissue to fight prostate cancerSilvano Paternoster, Marco Falasca
Frontiers in Endocrinology|October 27, 2018
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1Silvano Paternoster, Marco Falasca
Frontiers in Endocrinology|August 13, 2019
Editorial: Gastrointestinal HormonesSilvano Paternoster, Damien Keating, Marco Falasca
Advances in Biological Regulation|March 12, 2019
Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potentialAlice Domenichini, Jeanne S Edmands, Aleksandra Adamska, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2017
Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase PhosphorylationPeter V Simpson, Ilaria Casari, Silvano Paternoster, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2018
Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119Syamsul A Arifin, Silvano Paternoster, Rodrigo Carlessi, et al.
Pharmacological Research|August 19, 2021
Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimeticsSilvano Paternoster, Peter V Simpson, Elena Kokh, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Reviews on Cancer|November 11, 2019
The intricate relationship between diabetes, obesity and pancreatic cancerSilvano Paternoster, Marco Falasca
Translational Andrology and Urology|August 9, 2019
Targeting the adipose tissue to fight prostate cancerSilvano Paternoster, Marco Falasca
Frontiers in Endocrinology|October 27, 2018
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1Silvano Paternoster, Marco Falasca
Frontiers in Endocrinology|August 13, 2019
Editorial: Gastrointestinal HormonesSilvano Paternoster, Damien Keating, Marco Falasca
Advances in Biological Regulation|March 12, 2019
Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potentialAlice Domenichini, Jeanne S Edmands, Aleksandra Adamska, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2017
Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase PhosphorylationPeter V Simpson, Ilaria Casari, Silvano Paternoster, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2018
Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119Syamsul A Arifin, Silvano Paternoster, Rodrigo Carlessi, et al.
Pharmacological Research|August 19, 2021
Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimeticsSilvano Paternoster, Peter V Simpson, Elena Kokh, et al.
Pageof 1